000 | 01671 a2200457 4500 | ||
---|---|---|---|
005 | 20250511214442.0 | ||
264 | 0 | _c19900802 | |
008 | 199008s 0 0 eng d | ||
022 | _a0031-9384 | ||
024 | 7 |
_a10.1016/0031-9384(90)90133-o _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGosnell, B A | |
245 | 0 | 0 |
_aEffects of preferential delta and kappa opioid receptor agonists on the intake of hypotonic saline. _h[electronic resource] |
260 |
_bPhysiology & behavior _cMar 1990 |
||
300 |
_a601-3 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _a3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aDrinking _xdrug effects |
650 | 0 | 4 |
_aDynorphins _xanalogs & derivatives |
650 | 0 | 4 |
_aEating _xdrug effects |
650 | 0 | 4 | _aEnkephalin, D-Penicillamine (2,5)- |
650 | 0 | 4 |
_aEnkephalins _xpharmacology |
650 | 0 | 4 |
_aFood Preferences _xdrug effects |
650 | 0 | 4 | _aHypotonic Solutions |
650 | 0 | 4 | _aInjections, Intraventricular |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOligopeptides _xpharmacology |
650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Strains |
650 | 0 | 4 |
_aReceptors, Opioid _xdrug effects |
650 | 0 | 4 | _aReceptors, Opioid, delta |
650 | 0 | 4 | _aReceptors, Opioid, kappa |
650 | 0 | 4 | _aTaste |
700 | 1 | _aMajchrzak, M J | |
700 | 1 | _aKrahn, D D | |
773 | 0 |
_tPhysiology & behavior _gvol. 47 _gno. 3 _gp. 601-3 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0031-9384(90)90133-o _zAvailable from publisher's website |
999 |
_c1978982 _d1978982 |